Return to Special Authority drug list
Generic name |
adalimumab |
|
---|---|---|
Brand name |
Strength |
Form |
Abrilada | 20 mg/0.4 mL | pre-filled syringe |
40 mg/0.8 mL | pre-filled syringe pre-filled pen |
|
Amgevita | 20 mg/0.4 mL | pre-filled syringe |
40 mg/0.8 mL | pre-filled syringe autoinjector |
|
Hadlima | 40 mg/0.4 mL | autoinjector pre-filled syringe |
40 mg/0.8 mL | pre-filled syringe autoinjector |
|
Hulio | 20 mg/0.4 mL | pre-filled syringe |
40 mg/0.8 mL | pre-filled syringe autoinjector |
|
Hyrimoz | 20 mg/0.2 mL | pre-filled syringe |
40 mg/0.4 mL | pre-filled syringe autoinjector |
|
80 mg/0.8 mL | pre-filled syringe autoinjector |
|
20 mg/0.4 mL | pre-filled syringe | |
40 mg/0.8 mL | pre-filled syringe autoinjector |
|
Idacio | 40 mg/0.8 mL | pre-filled syringe pre-filled pen |
Simlandi | 40 mg/0.4 mL | pre-filled syringe autoinjector |
80 mg/0.8 mL | pre-filled syringe | |
Yuflyma | 40 mg/0.4 mL | pre-filled syringe pre-filled pen |
80 mg/0.8mL | pre-filled syringe pre-filled pen |
Special Authority criteria |
Approval period |
---|---|
InitialFor the treatment of active1 non-infectious uveitis (NIU) in patients 2 years and older who meet ALL the following criteria:
AND
|
1 year |
Renewal
AND
|
1 year |